Subcutaneous fat is not inherently bad. It’s the layer of fat sitting just beneath your skin, and it serves essential biological functions: storing energy, insulating your body against heat loss, and cushioning organs and tissues. In many cases, subcutaneous fat is actually protective against metabolic disease. The fat you should be more concerned about is visceral fat, the deeper fat that wraps around your internal organs.
That said, subcutaneous fat isn’t always harmless. Like most things in the body, the story depends on how much you have, where it’s stored, and whether the fat cells themselves are functioning normally.
What Subcutaneous Fat Actually Does
Your body stores most of its fat as white adipose tissue, and subcutaneous fat is the largest depot of it. It spreads throughout your body just beneath the skin, and its two primary jobs are energy storage and insulation. When you eat more calories than you burn, subcutaneous fat cells expand to store that energy for later use. When you’re exposed to cold, this fat layer helps retain body heat. In sustained cold exposure, subcutaneous fat can even shift toward a more metabolically active form that generates heat directly, a process called “browning.”
Subcutaneous fat is also an active hormonal organ. It produces leptin, a hormone that signals your brain about energy reserves and helps regulate appetite. It also secretes adiponectin, a hormone that improves insulin sensitivity and helps your body process blood sugar. When subcutaneous fat is functioning well, these hormonal signals keep your metabolism in balance.
Why It’s Considered the “Safer” Fat
Visceral fat, the fat packed around your liver, intestines, and other abdominal organs, is far more strongly linked to metabolic problems like insulin resistance, type 2 diabetes, high blood pressure, and cardiovascular disease. Visceral fat cells release significantly higher levels of inflammatory molecules compared to subcutaneous fat cells. That chronic, low-grade inflammation is a major driver of metabolic disease.
Subcutaneous fat, by contrast, tends to grow by making new fat cells rather than inflating existing ones to dangerous sizes. This matters because smaller, more numerous fat cells function better than fewer, overstuffed ones. Visceral fat is more prone to the opposite pattern: cells that bloat up, become oxygen-starved, and trigger inflammation.
Research in mice has shown that transplanting subcutaneous fat into the abdominal cavity actually improved glucose metabolism and reduced total body weight. That finding suggests subcutaneous fat is intrinsically different from visceral fat in ways that benefit the body. Medications that increase total fat mass primarily in subcutaneous stores have also been shown to improve insulin sensitivity, further supporting the idea that this fat depot is metabolically favorable.
The Protective Buffer Theory
One of the most important roles of subcutaneous fat is acting as a safe place to store excess calories. When your body takes in more energy than it needs, that energy has to go somewhere. If subcutaneous fat can absorb it, the surplus stays out of places where it causes real damage: the liver, the pancreas, skeletal muscle, and the spaces around your organs.
This concept is sometimes called the “ectopic fat hypothesis.” When subcutaneous fat runs out of storage capacity, fat spills over into these vulnerable tissues and organs. That spillover disrupts normal function, damages cells, and drives insulin resistance. In this framework, subcutaneous fat is protective precisely because it prevents fat from accumulating where it shouldn’t be.
The clearest evidence for this comes from lipodystrophy, a condition where people have too little subcutaneous fat. Without adequate subcutaneous storage, fat deposits in the liver and other organs, leading to severe insulin resistance, type 2 diabetes, dangerously high triglycerides, fatty liver disease, liver fibrosis, and recurrent pancreatitis. The drop in leptin production alone creates a cascade of metabolic problems. Having too little subcutaneous fat is, in many ways, more dangerous than having a moderate excess.
Where It’s Stored Changes the Picture
Not all subcutaneous fat behaves the same way. Fat stored in your hips, thighs, and buttocks (called gluteofemoral fat) appears to be actively protective against metabolic disease. One study found that each increase in thigh fat led to a 59% decrease in the odds of developing insulin resistance, independent of age, BMI, visceral fat levels, and sex. Higher thigh fat is associated with lower triglycerides, higher levels of “good” HDL cholesterol, and lower blood glucose.
Gluteofemoral fat also appears to protect your cardiovascular system. Higher fat storage in this region is associated with less arterial stiffness, lower aortic calcification, and slower progression of existing calcification. The mechanisms behind this are well documented: lower-body fat breaks down more slowly than abdominal fat, keeping fewer fatty acids circulating in your blood. It produces higher levels of protective hormones like leptin and adiponectin while secreting lower levels of inflammatory molecules.
Abdominal subcutaneous fat, on the other hand, occupies a middle ground. It’s not as harmful as visceral fat, but it’s not as protective as hip and thigh fat either. Abdominal fat cells are 10 to 20 times more sensitive to signals that trigger fat breakdown, which means they release fatty acids into the bloodstream more readily.
When Subcutaneous Fat Becomes a Problem
Subcutaneous fat can turn harmful when its storage capacity is overwhelmed. In the subcutaneous depot, fat expansion starts with the creation of new cells, a healthy process. But when that capacity maxes out, existing cells begin to swell. Once a fat cell exceeds roughly 100 micrometers in diameter, oxygen can no longer diffuse to its center effectively. These overgrown cells become oxygen-starved, stiff, and inflamed. Immune cells infiltrate the tissue, fibrosis develops, and the fat depot shifts from protective to dysfunctional.
At that point, subcutaneous fat starts behaving more like visceral fat. Adiponectin production drops, which is an early warning sign of metabolic risk. The tissue becomes less responsive to insulin, and its ability to safely store excess energy diminishes. This is when fat begins spilling into the liver, muscles, and organs.
The threshold where this happens varies from person to person. Genetics play a significant role in determining how much subcutaneous fat your body can accommodate before cells become dysfunctional. This is one reason why two people at the same weight can have very different metabolic health profiles.
How Fat Distribution Is Assessed
Current clinical guidelines are moving beyond BMI alone to evaluate fat-related health risks. The 2024 European Association for the Study of Obesity guidelines recommend waist circumference as an indicator of visceral fat accumulation and waist-to-height ratio as a marker of excessive fat. A recent Lancet commission defined obesity as excess fat with or without abnormal distribution or function, distinguishing between “preclinical obesity” (excess fat but preserved organ function) and “clinical obesity” (excess fat actively impairing organs).
If you want to measure your own fat distribution, the most accurate clinical tool is a DEXA scan, which has a measurement precision within about 2% on repeated tests. Skinfold calipers are widely used and correlate well with DEXA results when the person measuring is well trained, though they tend to slightly underestimate fat percentage. Bioelectrical impedance devices (the kind built into smart scales) underestimate fat percentage even more.
Waist circumference remains the simplest and most practical way to gauge whether your fat distribution leans toward the riskier visceral pattern. You don’t need imaging to know whether your fat is concentrated around your midsection versus your hips and thighs, and that distinction matters more for your health than total subcutaneous fat alone.